[4-(2,6-dioxo-1-propyl-3,7-dihydropurin-8-yl)phenyl]sulfonyloxypotassium (409344-71-4)

Identification
Name:	[4-(2,6-dioxo-1-propyl-3,7-dihydropurin-8-yl)phenyl]sulfonyloxypotassium
Synonyms:	Benzenesu;Potassium
CAS:	409344-71-4
Molecular Formula:	C₁₄H₁₃KN₄O₅S
Molecular Weight:	388.4401
InChI:	InChI=1/C14H14N4O5S.K/c1-2-7-18-13(19)10-12(17-14(18)20)16-11(15-10)8-3-5-9(6-4-8)24(21,22)23;/h3-6H,2,7H2,1H3,(H,15,16)(H,17,20)(H,21,22,23);/q;+1/p-1/rC14H13KN4O5S/c1-2-7-19-13(20)10-12(18-14(19)21)17-11(16-10)8-3-5-9(6-4-8)25(22,23)24-15/h3-6H,2,7H2,1H3,(H,16,17)(H,18,21)
Molecular Structure:
Properties
Safety Data

Other Product

[(2R,3S,5R)-5-[2-amino-7-[2-(2-hydroxyethylsulfanyl)ethyl]-6-oxo-3,8-dihydropurin-9-yl]-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
[(2E)-1-(6-hydroxy-6-oxo-hexyl)-2-[(E)-3-[1-(6-hydroxy-6-oxo-hexyl)-3,3-dimethyl-5-sulfonato-indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-5-yl]sulfonyloxypotassium
1-(3-methyl-2,6-dioxo-7-{3-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]propyl}-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide
[1-(6-hydroxy-6-oxo-hexyl)-2,3,3-trimethyl-indol-1-ium-5-yl]sulfonyloxypotassium
Cyclopentanecarboxamide,N-[4-[2-(8-cyclopentyl-1,2,6,9-tetrahydro-2,6-dioxo-1-propyl-3H-purin-3-yl)ethyl]phenyl]-
Acetamide,N-[4-[2-(8-cyclopentyl-1,2,6,9-tetrahydro-2,6-dioxo-1-propyl-3H-purin-3-yl)ethyl]phenyl]-
2-amino-3,7-dihydropurin-6-one
7H-Pyrrolo[2,3-d]pyrimidine-2-carbonitrile,7-(2,2-dimethylpropyl)-6-[(1-methyl-2,4-dioxo-3-propyl-1,3,8-triazaspiro[4.5]dec-8-yl)methyl]-
7H-Pyrrolo[2,3-d]pyrimidine-2-carbonitrile,7-(2,2-dimethylpropyl)-6-[(3-methyl-2,4-dioxo-1-propyl-1,3,8-triazaspiro[4.5]dec-8-yl)methyl]-
7H-Pyrrolo[2,3-d]pyrimidine-2-carbonitrile,7-(2,2-dimethylpropyl)-6-[(1-methyl-2,4-dioxo-8-propyl-1,3,8-triazaspiro[4.5]dec-3-yl)methyl]-
[(2R,3S,4R,5R)-5-(2-amino-6,8-dioxo-3,7-dihydropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
(1-allylcyclopropyl)sulfonyloxypotassium
phenylmercury(1+) 2-amino-6-oxo-9-pentofuranosyl-6,9-dihydropurin-1-ide
Acetic acid,[4-[3-[2-[4-azido-3-(iodo-125I)phenyl]ethyl]-2,3,6,7-tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl]phenoxy]-(9CI)
Piperazine,1-[3-[3-methoxy-4-[(2-methoxyethoxy)methoxy]phenyl]-1-oxo-2-propenyl]-4-[3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl]-,(E)-
2,6-dibromo-4-[7-(3,5-dibromo-4-hydroxy-2-methyl-phenyl)-9,9-dioxo-8-oxa-9$l^{6}-thiabicyclo[4.3.0]nona-1,3,5-trien-7-yl]-3-methyl-phenol; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline
3,7-dihydropurin-6-amine
Morpholine,4-[[[2-[[8-(3-amino-1-piperidinyl)-7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]acetyl]phenyl]amino]acetyl]-
Piperazine,1-[5-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-1-oxo-2,4-pentadienyl]-4-[3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl]-,(E,E)-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[1,3-dioxo-2-phenyl-3-(phenylmethoxy)propyl]amino]-3,3-dimethyl-7-oxo-,monosodium salt, [2S-(2a,5a,6b)]- (9CI)